晖致Viatris（VTRS）2025年第四季度及全年业绩报告「NASDAQ」（英文版）（14页）.pdf

1、Viatris Reports Fourth-Quarter and Full-Year 2025 Financial ResultsFebruary 26,2026Reports Fourth-Quarter Total Revenues of$3.7B and Full-Year 2025 Total Revenues of$14.3BMeets or Exceeds 2025 Financial Guidance Across All Key Metrics1Returns More Than$1B to Shareholders in 2025;Expects Balanced Cap

2、ital Allocation Approach for 2026Provides 2026 Financial Guidance;Positioned for Sustainable GrowthAnticipates Regulatory Decisions for Six Product Candidates in 2026 and Multiple Important Pipeline MilestonesCompletes Enterprise-Wide Strategic Review;Expects to Deliver$650M in Total Cost Savings Wi

3、th Reinvestment of up to$250M Over the Next 3 YearsPITTSBURGH,Feb.26,2026/PRNewswire/-Viatris Inc.(Nasdaq:VTRS)today announced robust financial results for the fourth quarter and full year2025.The Company also announced it has completed its enterprise-wide strategic review and expects to deliver mea

4、ningful net cost savings whileenabling reinvestment in areas that enhance the growth profile and long-term competitiveness of the Company.Executive Commentary2025 was a year of strong execution across our global business,and we enter 2026 from a position of strength,said Scott A.Smith,CEO,Viatris.To

5、day marks an important inflection point in Viatris evolution.We have just completed our enterprise-wide strategic review to help make Viatris amore focused,efficient and future-ready organization.By realigning resources and prioritizing investments in the areas we believe will drive thegreatest impa

6、ct,we are positioning Viatris to deliver sustained revenue and earnings growth beginning in 2026.As we look ahead to our InvestorEvent on March 19,we are excited to share more about our strategy,our portfolio and how we intend to create lasting value for patients andshareholders.Our strong performan